2026 Keyword Index
Published in Volume 22, Issue 4 (2026)
A
- acute complications, 285
- advocates, 383
- aesthetic outcome, 447
- aesthetic outcomes, 340
- algorithm, 199
- antibody-drug conjugates, 240
- artificial intelligence, 35, 218
- autologous reconstruction, 285
- Avelumab, 505
- axillary lymph node, 358
- axillary lymph node dissection, 441
- axillary lymphadenectomy, 61
- azathioprine, 270
B
- B-mode measurements, 381
- B3 lesions, 523
- baby oil, 234
- baseline data, 426
- benign, 501
- Benign breast lumps, 476
- bilobed flap, 455
- biological matrices, 25
- biomarkers, 218
- body composition, 139, 485
- boost, 66
- BRCA1 and BRCA2 genes, 92
- BRCA1 gene, 156
- BRCA2 gene, 156
- Breast, 363, 466
- Breast augmentation, 234
- breast biopsy, 523
- Breast cancer, 1, 25, 44, 54, 61, 66, 78, 87, 92, 115, 139, 156, 165, 171, 184, 248, 261, 279, 285, 318, 372, 372, 374, 386, 393, 426, 441, 494, 511, 518
- Breast cancer awareness, 147
- Breast cancer screenings, 106
- breast cancer-related lymphedema, 441
- Breast carcinoma, 485
- breast disease, 231
- breast diseases, 126
- breast feeding, 98
- Breast imaging, 92, 106, 358, 520
- Breast implant, 434
- breast implant-associated anaplastic large cell lymphoma, 466
- Breast MRI, 407
- Breast neoplasms, 184, 218, 350, 447
- breast reconstruction, 209, 285, 294, 393
- breast self-examination, 147
- breast surgery, 35, 476, 494
- breast-conserving surgery, 294, 340, 447, 455, 494, 511
C
- calcifications, 358
- CD56 marker, 505
- cell-cycle/mitotic targets, 240
- central breast cancer, 340
- CGRA, 374
- Chest wall perforator flaps, 294, 393
- China, 373
- chronic mastitis, 126
- CK20 positivity, 505
- classification, 199
- clinical decision support systems, 35
- codes, 382
- Colonic breast metastasis, 102
- comorbidity, 261
- complete remission, 417
- computed tomography, 485
- contrast enhanced mammogram, 520
- contrast media, 520
- core biopsy, 520
- cost-effectiveness, 87
D
E
F
G
H
I
- IBC, 382
- Idiopathic, 199
- Idiopathic granulomatous mastitis, 126, 270, 417
- ileocecal metastasis, 102
- image guided biopsy, 156, 520
- immediate lymphatic reconstruction, 441
- immunohistochemistry, 501
- immunosuppressive therapy, 270
- immunotherapy, 240
- implant rupture, 434
- India, 165
- inflammatory breast disease, 126
- inflammatory lesions, 126
- inframammary fold, 209
- international, 373
- international survey, 328
- intraoperative ultrasound, 279
- invasive lobular carcinoma, 102
J
K
- Ki-67, 505
L
M
- machine learning, 35, 218, 307
- Magee equations (TM), 87
- magnetic resonance imaging, 44, 156, 328, 350, 434
- male breast, 501
- mammaplasty, 72
- mammography, 92, 106, 218, 372, 520
- mammoplasty, 226
- margin assessment, 279
- mastectomy, 78, 171
- mastitis, 199
- merkel cell carcinoma, 505
- merkel cell carcinoma of the breast, 505
- mesenchymal tumor, 501
- metabolic reprogramming, 240
- metastasis, 386
- methotrexate, 270
- mid-treatment, 44
- minimally invasive breast surgery, 476
- minimally invasive mastectomy, 370
- minimally invasive surgery, 165
- modified radical mastectomy, 494
- mRNA expression, 248
- multidisciplinary, 1, 115
- muscular weakness, 378
- mutation, 156
- Myeloid sarcoma, 363
- myofascial adhesion, 54
- myofascial dysfunction, 54
- Myofibroblastoma, 501
N
O
P
- partial breast reconstruction, 455
- pathologic complete response, 44, 350
- pathology, 115
- patient reported outcomes, 494
- perforator flap, 72
- personalised oncology, 372
- polytetrafluoroethylene, 209
- post neoadjuvant systemic therapy, 19
- postoperative morbidity, 61
- practice patterns, 328
- precision oncology, 240
- predictive models, 35
- predictive value of tests, 350
- predictors, 426
- preoperative staging, 328
- primary angiosarcoma, 92
- prognostic markers, 248
- prospective trial, 66
- pseudocalcifications, 106
- Public awareness, 372
Q
R
- radiation oncology, 115
- radiation therapy, 511
- Radiation-induced angiosarcoma, 511
- radiology, 115
- radiotherapy, 66, 494
- randomized controlled trial, 426
- real-world data, 318
- reconstruction, 165
- recurrence, 307, 417
- reduction mammoplasty, 98
- relapse, 270
- research gaps, 382
- retrospective observational study, 393
- risk-adapted treatment, 270
- robotic breast surgery, 476
- robotic mastectomy, 165, 370
S
- S-LYMPHA, 441
- sarcopenia, 139
- scar tissue, 54
- screening, 147, 372
- SDHx, 379
- second-line breast biopsy, 190
- secondary malignancy, 511
- self-injection, 234
- sentinel lymph node biopsy, 61, 518
- sentinel lymph nodes, 518
- skeletal muscle index, 485
- South Africa, 372, 376, 384, 385
- specimen mammography, 279
- spontaneous remission, 417
- Staging, 384
- standards, 375
- STROBE, 494
- surgery, 115, 190, 386
- surgical approach, 78
- Surgical complications, 285
- surgical de-escalation, 523
- surgical delay, 374
- surgical flaps, 72
- surgical management, 407
- surgical margins, 340
- survival, 374, 386
- survival analysis, 248, 318
- Survivor, 386
- survivorship, 372
- systematic review, 374
- systemic, 1


